Style | Citing Format |
---|---|
MLA | Moradi S, Jahaniannajafabadi A, Roudkenar MH. "Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility." Clinical Medicine Insights: Blood Disorders, vol. 9, no. , 2016, pp. 33-41. |
APA | Moradi S, Jahaniannajafabadi A, Roudkenar MH (2016). Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility. Clinical Medicine Insights: Blood Disorders, 9(), 33-41. |
Chicago | Moradi S, Jahaniannajafabadi A, Roudkenar MH. "Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility." Clinical Medicine Insights: Blood Disorders 9, no. (2016): 33-41. |
Harvard | Moradi S, Jahaniannajafabadi A, Roudkenar MH (2016) 'Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility', Clinical Medicine Insights: Blood Disorders, 9(), pp. 33-41. |
Vancouver | Moradi S, Jahaniannajafabadi A, Roudkenar MH. Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility. Clinical Medicine Insights: Blood Disorders. 2016;9():33-41. |
BibTex | @article{ author = {Moradi S and Jahaniannajafabadi A and Roudkenar MH}, title = {Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility}, journal = {Clinical Medicine Insights: Blood Disorders}, volume = {9}, number = {}, pages = {33-41}, year = {2016} } |
RIS | TY - JOUR AU - Moradi S AU - Jahaniannajafabadi A AU - Roudkenar MH TI - Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility JO - Clinical Medicine Insights: Blood Disorders VL - 9 IS - SP - 33 EP - 41 PY - 2016 ER - |